Search
DEEN
more info

Contact:
Phone:+49 0761 1514 440Fax:+49 0761 1514 460Email:info[at]falkfoundation.org

    Falk Gastro Review Journal

    Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

    Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

    The latest issues

    Edition 3/2024

    read more

    Edition 2/2024

    read more

    Edition 1/2024

    read more

    Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

    All articles

    Esophagus to Small Intestine

    Real-world efficacy of dupilumab in severe, treatment-refractory, and fibrostenotic patients with eosinophilic esophagitis

    Clin Gastroenterol Hepatol. 2024;22(2):252–8

    Lee CJ, Dellon ES

    Go to article

    Esophagus to Small Intestine

    Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic esophagitis: A subgroup analysis of the phase 3 LIBERTY EoE TREET study

    Gut. 2024;73(3):398–406

    Bredenoord AJ, Dellon ES, Hirano I, Lucendo AJ, Schlag C, Sun X, Glotfelty L, Mannent L, Maloney J, Laws E, Mortensen E, Shabbir A

    Go to article

    Esophagus to Small Intestine

    The effect of nationwide organized cancer screening programs on gastric cancer mortality: A synthetic control study

    Gastroenterology. 2024;166(3):503–14

    Sun D, Mülder DT, Li Y, Nieboer D, Park JY, Suh M, Hamashima C, Han W, O‘Mahony JF, Lansdorp-Vogelaar I

    Go to article

    Esophagus to Small Intestine

    Prevalence and predictors of Barrett’s esophagus after negative initial endoscopy: Analysis from 2 national databases

    Clin Gastroenterol Hepatol. 2024;22(3):523–31.e3

    Dhaliwal L, Kamboj AK, Williams JL, Chandar AK, Sachdeva K, Gibbons E, Lansing R, Passe M, Perez JA, Avenir KLR, Martin SA, Leggett CL, Chak A, Falk GW, Wani S, Shaheen NJ, Kisiel JB, Iyer PG

    Go to article

    Esophagus to Small Intestine

    Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastroesophageal cancer (KEYNOTE-585): An interim analysis of the multicenter, double-blind, randomized phase 3 study

    Lancet Oncol. 2024;25(2):212–24

    Shitara K, Rha SY, Wyrwicz LS, Oshima T, Karaseva N, Osipov M, Yasui H, Yabusaki H, Afanasyev S, Park YK, Al-Batran SE, Yoshikawa T, Yanez P, Di Bartolomeo M, Lonardi S, Tabernero J, Van Cutsem E, Janjigian YY, Oh DY, Xu J, Fang X, Shih CS, Bhagia P, Bang YJ; KEYNOTE-585 investigators

    Go to article

    Esophagus to Small Intestine

    Perioperative atezolizumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable esophagogastric cancer: Interim results from the randomized, multicenter, phase 2/3 DANTE/IKF-s633 trial

    J Clin Oncol. 2024;42(4):410–20

    Lorenzen S, Götze TO, Thuss-Patience P, Biebl M, Homann N, Schenk M, Lindig U, Heuer V, Kretzschmar A, Goekkurt E, Haag GM, Riera-Knorrenschild J, Bolling C, Hofheinz RD, Zhan T, Angermeier S, Ettrich TJ, Siebenhuener AR, Elshafei M, Bechstein WO, Gaiser T, Loose M, Sookthai D, Kopp C, Pauligk C, Al-Batran SE; AIO and SAKK Study Working Groups

    Go to article

    Esophagus to Small Intestine

    Effect of hyperthermic intraperitoneal chemotherapy on cytoreductive surgery in gastric cancer with synchronous peritoneal metastases: The Phase 3 GASTRIPEC-I trial

    J Clin Oncol. 2024;42(2):146–56

    Rau B, Lang H, Koenigsrainer A, Gockel I, Rau HG, Seeliger H, Lerchenmueller C, Reim D, Wahba R, Angele M, Heeg S, Keck T, Weimann A, Topp S, Piso P, Brandl A, Schuele S, Jo P, Pratschke J, Wegel S, Rehders A, Moosmann N, Gaedcke J, Heinemann V, Trips E, Loeffler M, Schlag PM, Thuss-Patience P

    Go to article

    Esophagus to Small Intestine

    Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: A population-based systematic analysis of GLOBOCAN

    Lancet Gastroenterol Hepatol. 2024;9(3):229–37

    Wang S, Zheng R, Li J, Zeng H, Li L, Chen R, Sun K, Han B, Bray F, Wei W, He J

    Go to article

    Esophagus to Small Intestine

    Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial

    JAMA. 2024;331(1):38–48

    Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY, Ahmad NN, Zhang S, Liao R, Bunck MC, Jouravskaya I, Murphy MA; SURMOUNT-4 Investigators

    Go to article